Synthesis, In Vitro Profiling, and In Vivo Evaluation of Benzohomoadamantane-Based Ureas for Visceral Pain: A New Indication for Soluble Epoxide Hydrolase Inhibitors.


Journal

Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531

Informations de publication

Date de publication:
27 10 2022
Historique:
pubmed: 13 10 2022
medline: 29 10 2022
entrez: 12 10 2022
Statut: ppublish

Résumé

The soluble epoxide hydrolase (sEH) has been suggested as a pharmacological target for the treatment of several diseases, including pain-related disorders. Herein, we report further medicinal chemistry around new benzohomoadamantane-based sEH inhibitors (sEHI) in order to improve the drug metabolism and pharmacokinetics properties of a previous hit. After an extensive in vitro screening cascade, molecular modeling, and in vivo pharmacokinetics studies, two candidates were evaluated in vivo in a murine model of capsaicin-induced allodynia. The two compounds showed an anti-allodynic effect in a dose-dependent manner. Moreover, the most potent compound presented robust analgesic efficacy in the cyclophosphamide-induced murine model of cystitis, a well-established model of visceral pain. Overall, these results suggest painful bladder syndrome as a new possible indication for sEHI, opening a new range of applications for them in the visceral pain field.

Identifiants

pubmed: 36222708
doi: 10.1021/acs.jmedchem.2c00515
pmc: PMC9620236
doi:

Substances chimiques

Epoxide Hydrolases EC 3.3.2.-
Urea 8W8T17847W
Capsaicin S07O44R1ZM
Enzyme Inhibitors 0
Analgesics 0
Cyclophosphamide 8N3DW7272P

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

13660-13680

Subventions

Organisme : NIEHS NIH HHS
ID : P42 ES004699
Pays : United States
Organisme : NIEHS NIH HHS
ID : R35 ES030443
Pays : United States

Références

J Comput Chem. 2004 Jul 15;25(9):1157-74
pubmed: 15116359
Pharmacol Biochem Behav. 2013 Sep;110:98-103
pubmed: 23792539
J Clin Pharmacol. 2012 Mar;52(3):319-28
pubmed: 21422238
Gene. 2015 Oct 15;571(1):1-8
pubmed: 26216302
Bioorg Med Chem Lett. 2013 Jul 1;23(13):3732-7
pubmed: 23726028
Neurotherapeutics. 2020 Oct;17(4):1825-1835
pubmed: 32488482
J Med Chem. 2021 Feb 25;64(4):1856-1872
pubmed: 33550801
Anal Biochem. 2005 Aug 1;343(1):66-75
pubmed: 15963942
Bioorg Med Chem. 2014 May 1;22(9):2678-83
pubmed: 24698811
Pain. 2009 Jun;143(3):252-261
pubmed: 19375855
Am J Physiol Cell Physiol. 2007 Mar;292(3):C996-1012
pubmed: 16987999
Science. 2001 Nov 30;294(5548):1871-5
pubmed: 11729303
Angew Chem Int Ed Engl. 2019 Mar 4;58(10):3097-3101
pubmed: 30600584
Front Pharmacol. 2019 May 08;10:464
pubmed: 31143115
Drug Discov Today. 2015 Nov;20(11):1382-90
pubmed: 26259523
Expert Opin Drug Metab Toxicol. 2009 Jul;5(7):757-71
pubmed: 19505190
Cancer Chemother Pharmacol. 2015 Jan;75(1):161-71
pubmed: 25413440
Prostaglandins Other Lipid Mediat. 2007 May;83(3):188-97
pubmed: 17481554
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Pharmacol Ther. 2017 Dec;180:62-76
pubmed: 28642117
J Chem Phys. 2004 Jun 22;120(24):11919-29
pubmed: 15268227
Neurosci Res. 2016 Oct;111:56-63
pubmed: 27184295
J Urol. 2003 Sep;170(3):1008-12
pubmed: 12913760
J Chem Phys. 2007 Oct 21;127(15):155102
pubmed: 17949218
Pharmacol Res. 2020 May;155:104724
pubmed: 32105755
Bioorg Med Chem Lett. 2006 Oct 1;16(19):5212-6
pubmed: 16870439
Gene. 2013 Sep 10;526(2):61-74
pubmed: 23701967
Nucleic Acids Res. 2011 Jul;39(Web Server issue):W270-7
pubmed: 21624888
Lancet. 2000 Sep 2;356(9232):785-7
pubmed: 11022922
Sci Rep. 2017 Mar 03;7:42717
pubmed: 28256516
Trends Mol Med. 2008 Oct;14(10):461-9
pubmed: 18774339
Bioorg Med Chem. 2015 Jan 15;23(2):290-6
pubmed: 25515953
J Pharmacol Exp Ther. 1998 Mar;284(3):966-73
pubmed: 9495856
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Neurotherapeutics. 2020 Jul;17(3):900-916
pubmed: 32875445
J Med Chem. 2010 Oct 14;53(19):7067-75
pubmed: 20812725
Front Pharmacol. 2018 May 01;9:433
pubmed: 29765323
J Adv Res. 2018 Mar 13;11:23-32
pubmed: 30034873
Bioorg Med Chem. 2019 Sep 1;27(17):3745-3759
pubmed: 31331653
Pharmaceuticals (Basel). 2021 Dec 17;14(12):
pubmed: 34959721
Bioinformatics. 2017 Nov 15;33(22):3658-3660
pubmed: 28961788
Eur J Med Chem. 2003 Mar;38(3):223-32
pubmed: 12667689
Drug Discov Today. 2015 Sep;20(9):1104-11
pubmed: 25931264
Drug Metab Dispos. 2015 May;43(5):788-802
pubmed: 25762541
ACS Chem Neurosci. 2019 Sep 18;10(9):4018-4030
pubmed: 31378059
J Med Chem. 2021 Jan 14;64(1):184-215
pubmed: 33369424
Pain. 2011 Mar;152(3 Suppl):S2-S15
pubmed: 20961685
J Urol. 2014 May;191(5):1294-9
pubmed: 24316091
Equine Vet J. 2017 May;49(3):345-351
pubmed: 27338788
Bioorg Med Chem. 2019 Oct 15;27(20):115078
pubmed: 31488357
J Pain Res. 2021 Jan 13;14:61-72
pubmed: 33488116
Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):9082-7
pubmed: 26150506
J Comput Chem. 2011 Jul 30;32(10):2149-59
pubmed: 21541955
Basic Clin Pharmacol Toxicol. 2014 Jan;114(1):83-91
pubmed: 24015667
J Med Chem. 2021 May 13;64(9):5429-5446
pubmed: 33945278
J Am Chem Soc. 2022 Apr 27;144(16):7146-7159
pubmed: 35412310
Bioorg Med Chem. 2012 Jan 15;20(2):942-8
pubmed: 22178660
Annu Rev Biophys Biomol Struct. 1999;28:155-79
pubmed: 10410799

Auteurs

Sandra Codony (S)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

José M Entrena (JM)

Animal Behavior Research Unit, Scientific Instrumentation Center, Parque Tecnológico de Ciencias de la Salud, University of Granada, Armilla, Granada 18100, Spain.

Carla Calvó-Tusell (C)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.

Beatrice Jora (B)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Rafael González-Cano (R)

Department of Pharmacology, Faculty of Medicine and Biomedical Research Center (Neurosciences Institute), Biosanitary Research Institute ibs.GRANADA, University of Granada, Avenida de la Investigación 11, Granada 18016, Spain.

Sílvia Osuna (S)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.
Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona 08010, Spain.

Rubén Corpas (R)

Institute of Biomedical Research of Barcelona (IIBB), CSIC and IDIBAPS, Barcelona 08036, Spain.

Christophe Morisseau (C)

Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, California 95616, United States.

Belén Pérez (B)

Department of Pharmacology, Therapeutics and Toxicology, Institute of Neurosciences, Autonomous University of Barcelona, Bellaterra, Barcelona 08193, Spain.

Marta Barniol-Xicota (M)

Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven─University of Leuven, Herestraat 49 box B901, Leuven 3000, Belgium.

Christian Griñán-Ferré (C)

Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av. Joan XXIII 27-31, Barcelona 08028, Spain.

Concepción Pérez (C)

Institute of Medicinal Chemistry, Spanish National Research Council (CSIC), C/Juan de la Cierva 3, Madrid 28006, Spain.

María Isabel Rodríguez-Franco (MI)

Institute of Medicinal Chemistry, Spanish National Research Council (CSIC), C/Juan de la Cierva 3, Madrid 28006, Spain.

Antón L Martínez (AL)

Drug Screening Platform/Biofarma Research Group, CIMUS Research Center, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.

M Isabel Loza (MI)

Drug Screening Platform/Biofarma Research Group, CIMUS Research Center, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.

Mercè Pallàs (M)

Pharmacology Section, Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Institute of Neuroscience, University of Barcelona (NeuroUB), Av. Joan XXIII 27-31, Barcelona 08028, Spain.

Steven H L Verhelst (SHL)

Laboratory of Chemical Biology, Department of Cellular and Molecular Medicine, KU Leuven─University of Leuven, Herestraat 49 box B901, Leuven 3000, Belgium.
Leibniz Institute for Analytical Sciences ISAS, AG Chemical Proteomics, Otto-Hahn-Str. 6b, Dortmund 44227, Germany.

Coral Sanfeliu (C)

Institute of Biomedical Research of Barcelona (IIBB), CSIC and IDIBAPS, Barcelona 08036, Spain.

Ferran Feixas (F)

CompBioLab Group, Departament de Química and Institut de Química Computacional i Catàlisi (IQCC), Universitat de Girona, C/ Maria Aurèlia Capmany 69, Girona 17003, Spain.

Bruce D Hammock (BD)

Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, California 95616, United States.

José Brea (J)

Drug Screening Platform/Biofarma Research Group, CIMUS Research Center, University of Santiago de Compostela (USC), Santiago de Compostela 15782, Spain.

Enrique J Cobos (EJ)

Department of Pharmacology, Faculty of Medicine and Biomedical Research Center (Neurosciences Institute), Biosanitary Research Institute ibs.GRANADA, University of Granada, Avenida de la Investigación 11, Granada 18016, Spain.

Santiago Vázquez (S)

Laboratori de Química Farmacèutica (Unitat Associada al CSIC), Facultat de Farmàcia i Ciències de l'Alimentació, and Institute of Biomedicine (IBUB), Universitat de Barcelona, Av. Joan XXIII, 27-31, Barcelona 08028, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH